Basic Information
Early is Good Develops Kidney Disease Diagnostic Products; Its First Product, BCDx, is a Laboratory-Developed Method for Early Detection of Bladder Cancer. The BCDx Test Uses Nanotechnology to Quantify a Set of Biomarkers Found in Patient Urine to Diagnose Bladder Cancer and Determine the Stage of the Disease.
Early is Good
Indianapolis,Indiana,United States of America
less than 15 people
January 01, 2019
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios